Joanna Y. Lee
Joanna Lee's consulting experience includes advising pharmaceutical, biotech, and medical device organizations as well as financial institutions. She consults on portfolio strategy, market entry strategy, product launch, life cycle management, global market access and reimbursement, and due diligence across a diverse set of therapeutic areas for prescription drug, OTC, consumer health and device products. Most of Ms. Lee’s engagements have a global focus, with a primary emphasis on the US, EU, and Japan, but she has also done work for clients in emerging markets such as Brazil, China, India, Mexico, and Russia.
Prior to joining CRA, Ms. Lee was Vice President with Leerink Swann Consulting and Senior Analyst with Insight Strategy Advisors where she focused on product pricing, reimbursement, and contracting strategies. Before that, as a research & development engineer at Angstrom Medica, she developed novel synthetic biomaterials for orthopaedic devices and developed the manufacturing process for the company’s calcium phosphate platform technology. Ms. Lee developed and managed testing to support the 510(k) application for Angstrom’s NanOssTM bone void filler, which was the first nanotechnology device to receive FDA clearance.
BS, Biology, Massachusetts Institute of Technology